CPG
AXSM icon

Cornerstone Planning Group’s Axsome Therapeutics AXSM Stock Holding History

Cornerstone Planning Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12K Hold
5
– – ﹤0.01% 1434
2025
Q4 		$926 Hold
5
– – ﹤0.01% 1371
2025
Q3 		$666 Hold
5
– – ﹤0.01% 1418
2025
Q2 		$518 Hold
5
– – ﹤0.01% 1289
2025
Q1 		$521 Hold
5
– – ﹤0.01% 1289
2024
Q4 		$513 Buy
+5
New +$460 ﹤0.01% 1126

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Planning Group's AXSM Position: Q1 2026 in Review

Cornerstone Planning Group held its Axsome Therapeutics (AXSM) position steady in Q1 2026 at 5 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1434.

Cornerstone Planning Group first reported a position in AXSM in Q4 2024 and has held it in 6 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Cornerstone Planning Group held 5 shares of Axsome Therapeutics worth $1.12K as of Q1 2026.
  • Cornerstone Planning Group left its Axsome Therapeutics share count unchanged in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #1434 holding.
  • Cornerstone Planning Group first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.